|
|
Article: Xencor Expands Management Team; Leverages $50 Million Series C Financing to Fuel Development Efforts.
- Article from:
- Business Wire
- Article date:
- July 19, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
BIOWIRE2K
MONROVIA, Calif.--(BW HealthWire)--July 19, 2001
Xencor today announced that E. William Radany, Ph.D. has joined the company as chief business officer and Joyce L. Morrison has joined as vice president, Intellectual Property.
Each has over 15 years of experience in their field working with life science companies. Xencor has used the proceeds from its November, 2000 $50 million Series C financing to develop a novel platform for the study of molecular interactions for the generation of new therapeutics and agricultural products using its proprietary ProCode(TM) technology. Xencor has ...